Board of Directors

  Rochelle Stenzler Ron Hosking Dr. Perry Molinoff
Anthony Giovinazzo Nan Hutchinson Tamar Howson
Ilan Oren Tomer Gold

Rochelle Stenzler

BSc. Phm, ICD.D, Chairperson of the Board

Rochelle Stenzler is currently the Chair of the Board of Directors of Cynapsus Therapeutics Inc., and also serves on both its Audit Committee and Corporate Governance and Compensation Committee. Rochelle has extensive experience as a senior operating executive in pharmacy retail and consumer packaged goods. Prior to establishing Rochelle Stenzler Consulting in 2004, she was President and Chief Executive Officer of Touchlogic Corporation. Previously, as President of International Operations for TLC Laser Eye Centers Inc., she served as co-COO of a $300 million laser vision correction business. In 1997, Rochelle was named President of Revlon Canada Inc. where she played a key role in the company’s restructuring. Between 1976 and 1988 Rochelle held increasingly more responsible and senior positions in the pharmacy sector rising to Senior Vice President Operations at Pharma Plus Drugmarts Ltd. In 1992 she was named President and General Manager of Pharma Plus, a position she held until 1997.

She also currently serves as a Board Director of the Humber River Hospital in Toronto, serving on its Governance, Quality Assurance and Finance Committees. In addition, Rochelle serves on the Advisory Board of Social Capital Partners, who are developing new approaches to addressing Canada's employment challenges. She is the former Chair of Enwave Energy Corporation and Chairman, Executive Committee Member of the Canadian Association of Chain Drug Stores. Her community involvement includes roles as a Member of the Advisory Board of the B’nai Brith Foundation and a long standing Director/Executive Committee role with YPO/WPO (Young Presidents’ Organization/World Presidents’ Organization), where she is currently Treasurer of WPO Ontario. Rochelle is a graduate of the University of Toronto with a BSc.Phm. and the Rotman School of Management, Institute of Corporate Directors, with an ICD.D.

Horizonatal Rule
About CynapsusLine SeperationAPL-130277 ProductLine SeperationParkinson's DiseaseLine SeperationInvestor RelationsLine SeperationContact & LegalLine Seperation

Copyright 2016, Cynapsus Therapeutics Inc.
All rights reserved.

Traded on